HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Alembic Pharmaceuticals expands strategic collaboration with DifGen Pharmaceuticals
Nov-04-2026

Alembic Pharmaceuticals has expanded its strategic collaboration with DifGen Pharmaceuticals (DifGen). Building on their existing relationship, including the joint venture in Canada, the expanded collaboration combines DifGen’s development and US manufacturing capabilities with Alembic’s established US commercial platform. DifGen will lead development, regulatory, manufacturing and supply activities, while Alembic Pharmaceuticals will manufacture select products and commercialise the portfolio in the US.

This collaboration further strengthens its complex generics franchise in the US. The portfolio expands Alembic’s exposure to differentiated opportunities, particularly in transdermal systems, complex injectables and other specialised dosage forms.

Alembic Pharmaceuticals is involved in manufacturing and marketing of India Formulations, International Generics, and Active Pharmaceutical Ingredients with vertical integration capabilities.


  RELATED NEWS >>